The Vetr crowd downgraded its rating for EXACT Sciences Corporation EXAS Thursday from the stock's previous rating of 4.5 stars (Strong Buy), issued two days ago, to three stars (Hold). Crowd sentiment at the time of the downgrade was cautious, with 75 percent of Vetr user ratings bearish.
Share price in Exact Sciences experienced a jump of more than 11 percent on Tuesday after it was announced that UnitedHealth Group Inc UNH would include coverage of Cologuard, the biotech company's intended alternative to a colonoscopy cancer screening procedure.
The Cologuard test came under fire several weeks prior to the announcement after Citron Research analyst Andrew Left criticized the efficacy of the product compared to its $649 list price.
By the end of Thursday's trading day, Exact Sciences was priced at $38.24 a share.
Learn how crowdsourced ratings could help you time the market.
The Vetr crowd's average target price for Exact Sciences is down at $35.91, which is still above the average analyst target price of $23.23. Less than 2 percent of Vetr users are holding Exact Sciences in their watch lists.
Related Links:
Vetr Issues 'Strong Buy' On Ambarella After Analyst Downgrade
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
